『ESG Ventures』のカバーアート

ESG Ventures

著者: Andrew Charles King
  • サマリー

  • Working to elevate the world through investment in ESG. Environmental, Social and Governance objectives is our guide to responsible venture investing.
    © 2024 Andrew Charles King
    続きを読む 一部表示
エピソード
  • Leadership Series - Luke Fox. CEO, WhiteFox.
    2021/04/29

    Speaking with one of the foremost experts in unmanned aerial vehicles (UAV), ubiquitously known as drones, who helps craft national and international regulations and standards for the future of drones about the importance of neurodiversity and emphasizing thinking beyond the box.  Additionally, his startup, WhiteFox, is the leader in counter-drone and drone airspace management, protecting some of the most high-profile events and most sensitive facilities in the US and abroad. 

    WhiteFox
    Tech: Cutting-edge drone mitigation (counter-drone and airspace management) products that ensure responsible UAV usage nationally and globally for a safer, better world.
    Fundraising: $26M.
    Founding: 2015.

    続きを読む 一部表示
    43 分
  • Leadership Series - Cindy McLaughlin. CEO, Envelope City.
    2021/04/29

    Wide-ranging discussion regarding smart cities of the future and the evolving urban landscape.  Expert insights on the future of urban innovation with imitable Cindy McLaughlin, one of the foremost CEOs in NYC.  Her company, Envelope City, uses bleeding-edge AI tech to optimize for zoning regulations and, opportunities for, parallel investment.  However, along with being a leader of one of the most innovative urban tech startups, Cindy is an incredible visionary.  

    Envelope City.
    Tech: Envelope is a SaaS tech startup that has a proprietary model that enables analyzing, visualizing, and scenario planning of real estate development under optimal zoning.
    Fundraising: $4M.
    Founded: 2015.

    続きを読む 一部表示
    28 分
  • Leadership Series - Neel Lakhani. Public Health and ESG Expert.
    2021/04/29

    Focused on climate change and ESG, Neel has conducted and is publishing an in-depth study on pharmaceutical production, carbon footprints and climate change.  This interview reviews the various ways in which pharmaceutical production can be optimized to reduce greenhouse gas emissions.  Drawing from personal experience as well as extensive consulting expertise, this podcast examines steps to mitigate the global carbon footprint of multinational pharmaceutical companies.  

    続きを読む 一部表示
    31 分

あらすじ・解説

Working to elevate the world through investment in ESG. Environmental, Social and Governance objectives is our guide to responsible venture investing.
© 2024 Andrew Charles King

ESG Venturesに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。